BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16047488)

  • 1. Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver.
    Yamaguchi A; Tazuma S; Nishioka T; Ohishi W; Hyogo H; Nomura S; Chayama K
    Dig Dis Sci; 2005 Jul; 50(7):1361-71. PubMed ID: 16047488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.
    Perlemuter G; Sabile A; Letteron P; Vona G; Topilco A; Chrétien Y; Koike K; Pessayre D; Chapman J; Barba G; Bréchot C
    FASEB J; 2002 Feb; 16(2):185-94. PubMed ID: 11818366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway.
    Yu JW; Sun LJ; Liu W; Zhao YH; Kang P; Yan BZ
    Int J Infect Dis; 2013 Jul; 17(7):e539-45. PubMed ID: 23510538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
    Komatsu M; Kimura T; Yazaki M; Tanaka N; Yang Y; Nakajima T; Horiuchi A; Fang ZZ; Joshita S; Matsumoto A; Umemura T; Tanaka E; Gonzalez FJ; Ikeda S; Aoyama T
    Biochim Biophys Acta; 2015 Mar; 1852(3):473-81. PubMed ID: 25533124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein.
    Clément S; Sobolewski C; Gomes D; Rojas A; Goossens N; Conzelmann S; Calo N; Negro F; Foti M
    Liver Int; 2019 Jul; 39(7):1226-1236. PubMed ID: 30938910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
    Sun HY; Lin CC; Tsai PJ; Tsai WJ; Lee JC; Tsao CW; Cheng PN; Wu IC; Chiu YC; Chang TT; Young KC
    Cell Microbiol; 2017 Apr; 19(4):. PubMed ID: 27665576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma.
    Kim KH; Hong SP; Kim K; Park MJ; Kim KJ; Cheong J
    Biochem Biophys Res Commun; 2007 Apr; 355(4):883-8. PubMed ID: 17331464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
    Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
    Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
    Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
    Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein.
    Fukasawa M; Tanaka Y; Sato S; Ono Y; Nitahara-Kasahara Y; Suzuki T; Miyamura T; Hanada K; Nishijima M
    Biol Pharm Bull; 2006 Sep; 29(9):1958-61. PubMed ID: 16946517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine.
    Bonfleur ML; Borck PC; Ribeiro RA; Caetano LC; Soares GM; Carneiro EM; Balbo SL
    Life Sci; 2015 Aug; 135():15-21. PubMed ID: 26092479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets.
    Clément S; Peyrou M; Sanchez-Pareja A; Bourgoin L; Ramadori P; Suter D; Vinciguerra M; Guilloux K; Pascarella S; Rubbia-Brandt L; Negro F; Foti M
    Hepatology; 2011 Jul; 54(1):38-49. PubMed ID: 21465511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.
    Cheng Y; Dharancy S; Malapel M; Desreumaux P
    World J Gastroenterol; 2005 Dec; 11(48):7591-6. PubMed ID: 16437683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
    Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
    J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein induces hepatic steatosis via Sirt1-dependent pathway.
    Zhang C; Wang J; Zhang H; Liu S; Lee HJ; Jin W; Cheng J
    Liver Int; 2018 May; 38(5):803-812. PubMed ID: 28898508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
    Dharancy S; Malapel M; Perlemuter G; Roskams T; Cheng Y; Dubuquoy L; Podevin P; Conti F; Canva V; Philippe D; Gambiez L; Mathurin P; Paris JC; Schoonjans K; Calmus Y; Pol S; Auwerx J; Desreumaux P
    Gastroenterology; 2005 Feb; 128(2):334-42. PubMed ID: 15685545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.